×
Hero Background
English
Chinese
French
Japanese
Korean
German
Spanish

Gangrene Market Size

ID: MRFR/Pharma/1343-HCR
90 Pages
Rahul Gotadki
October 2025

Gangrene Market Research Report Information, by Type (Dry Gangrene, Wet Gangrene, Gas Gangrene), Treatment (Vascular Surgery, Hyperbaric Oxygen Chamber, Amputation), End User (Hospital, Clinic, Rehabilitation Center) - Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Gangrene Market Infographic
Request Free Sample
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF

Gangrene Size

Gangrene Market Growth Projections and Opportunities

The market for gangrene is fundamentally affected by the high commonness of vascular diseases and diabetes. These circumstances frequently lead to compromised blood stream, expanding the risk of gangrene advancement. The rising rate of diabetes worldwide adds to the developing demand for medicines tending to diabetic-related gangrene. Peripheral artery disease, a typical vascular problem, is a key variable driving the gangrene market. Diminished blood supply to extremeties expands the gamble of tissue ischemia, rot, and ensuing gangrene arrangement, requiring clinical mediation and treatment choices. The worldwide maturing population is a critical supporter of the gangrene market. Old age is frequently connected with expanded defencelessness to vascular diseases and weakened injury mending, the two of which are risk factors for gangrene. As the older population develops, the demand for viable gangrene medicines rises. Trauma and critical contaminations are significant reasons for non-diabetic and non-vascular gangrene. Mishaps, injuries, or untreated contaminations can prompt tissue harm and decay, requiring brief clinical consideration and remedial mediations in the gangrene market. Surgical mediations are a foundation of gangrene treatment, particularly in situations where tissue expulsion or revascularization is required. The demand for surgical strategies, including debridement and removal, impacts the gangrene market, stressing the requirement for cutting edge surgical methods and postoperative consideration. The reception of telemedicine and remote examination advances is affecting the gangrene market, particularly in post-treatment care. These advancements empower healthcare suppliers to screen patients from a distance, guaranteeing convenient intercession and decreasing the risk of complexities or recurrence in people recuperating from gangrene.

Gangrene Market Size Graph
Author
Rahul Gotadki
Assistant Manager

He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

Get In Touch

Leave a Comment

Market Summary

As per MRFR analysis, the Gangrene Market Size was estimated at 1.52 USD Million in 2024. The Gangrene industry is projected to grow from 1.62 in 2025 to 2.82 by 2035, exhibiting a compound annual growth rate (CAGR) of 5.76 during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The Gangrene Market is experiencing notable growth driven by technological advancements and increasing healthcare awareness.

  • Technological advancements in treatment are reshaping the Gangrene Market, particularly in North America, which remains the largest market.
  • The Asia-Pacific region is emerging as the fastest-growing market, driven by rising healthcare expenditure and a focus on preventive care.
  • Wound care continues to dominate the market, while surgical treatment is rapidly gaining traction as a preferred option.
  • The rising incidence of diabetes and an aging population are significant drivers contributing to the market's expansion.

Market Size & Forecast

2024 Market Size 1.52 (USD Million)
2035 Market Size 2.82 (USD Million)
CAGR (2025 - 2035) 5.76%
Largest Regional Market Share in 2024 North America

Major Players

<p>Johnson & Johnson (US), Smith & Nephew (GB), MediWound Ltd. (IL), Acelity L.P. Inc. (US), 3M Company (US), B. Braun Melsungen AG (DE), ConvaTec Group PLC (GB), Mölnlycke Health Care AB (SE), Integra LifeSciences Corporation (US)</p>

Market Trends

The Gangrene Market is currently experiencing notable transformations driven by advancements in medical technology and an increasing awareness of wound care management. The rise in chronic diseases, coupled with an aging population, has led to a heightened incidence of conditions that predispose individuals to gangrene. Consequently, healthcare providers are focusing on innovative treatment modalities, including advanced wound dressings and surgical interventions, to address this critical health issue. Furthermore, the integration of telemedicine and digital health solutions is enhancing patient access to specialized care, thereby improving outcomes for those affected by gangrene. In addition, the Gangrene Market is witnessing a shift towards preventive measures and education, as stakeholders recognize the importance of early intervention. Public health initiatives aimed at educating communities about the risks associated with gangrene and the significance of timely medical attention are gaining traction. This proactive approach not only aims to reduce the incidence of gangrene but also fosters a more informed patient population. As the market evolves, collaboration among healthcare professionals, researchers, and policymakers will be essential in developing comprehensive strategies to combat this condition effectively.

Technological Advancements in Treatment

The Gangrene Market is increasingly influenced by technological innovations that enhance treatment efficacy. New surgical techniques and advanced wound care products are being developed, which may lead to improved patient outcomes. These advancements could potentially reduce recovery times and minimize complications associated with gangrene.

Growing Focus on Preventive Care

There is a noticeable trend towards preventive care within the Gangrene Market. Healthcare providers are emphasizing education and awareness campaigns to inform the public about the risks of gangrene. This shift aims to encourage early detection and timely intervention, which may significantly reduce the prevalence of this condition.

Integration of Telehealth Solutions

The integration of telehealth solutions is transforming the Gangrene Market by providing patients with easier access to specialized care. Remote consultations and digital monitoring tools are becoming more prevalent, allowing healthcare professionals to manage cases more effectively. This trend may enhance patient engagement and adherence to treatment plans.

Gangrene Market Market Drivers

Aging Population

The aging population worldwide is a critical driver of the Global Gangrene Market Industry. Older adults are more susceptible to chronic conditions, such as vascular diseases and diabetes, which can lead to gangrene. As the demographic shift towards an older population continues, the demand for effective management and treatment options for gangrene is expected to rise. This trend is particularly relevant in developed countries where healthcare systems are adapting to meet the needs of an aging populace. Consequently, the market is anticipated to grow significantly, reflecting the increasing healthcare demands of older individuals.

Rising Incidence of Diabetes

The increasing prevalence of diabetes globally contributes significantly to the Global Gangrene Market Industry. Diabetes can lead to complications such as peripheral artery disease and neuropathy, which elevate the risk of gangrene. In 2024, the market is projected to reach 1.9 USD Billion, driven by the need for effective treatment options for diabetic patients. As the number of individuals diagnosed with diabetes continues to rise, the demand for advanced wound care products and therapies is likely to expand, thereby influencing market growth. This trend underscores the importance of addressing diabetic complications in the context of gangrene.

Advancements in Medical Technology

Technological innovations in medical devices and treatment methodologies are reshaping the Global Gangrene Market Industry. The introduction of advanced imaging techniques, such as MRI and CT scans, enhances the early detection of gangrene, facilitating timely intervention. Moreover, the development of novel wound care products, including bioengineered skin substitutes, is expected to improve patient outcomes. As these technologies become more widely adopted, they may contribute to a projected market growth rate of 7.86% CAGR from 2025 to 2035. This evolution in medical technology signifies a pivotal shift in how gangrene is diagnosed and treated.

Increasing Awareness and Education

There is a growing emphasis on public awareness and education regarding gangrene and its risk factors within the Global Gangrene Market Industry. Health organizations are actively promoting information campaigns aimed at educating the public about the symptoms, prevention, and treatment options for gangrene. This heightened awareness is likely to lead to earlier diagnosis and treatment, which can significantly reduce the incidence of severe cases. As a result, the market may experience a surge in demand for educational resources and healthcare services, ultimately contributing to the projected market value of 4.36 USD Billion by 2035.

Rising Incidence of Traumatic Injuries

The Global Gangrene Market Industry is also influenced by the rising incidence of traumatic injuries, which can lead to gangrene. Accidents, natural disasters, and combat-related injuries often result in severe wounds that may become infected, increasing the risk of gangrene. As global awareness of trauma care improves, there is a growing need for effective treatment options to manage these injuries. This trend is likely to drive market growth as healthcare providers seek advanced solutions to prevent complications associated with traumatic injuries, thereby enhancing patient care.

Market Segment Insights

By Application: Wound Care (Largest) vs. Surgical Treatment (Fastest-Growing)

<p>In the Gangrene Market, the application segments are diverse, but Wound Care currently holds the largest market share due to its critical role in the treatment of gangrene. This segment encompasses various products and therapies dedicated to managing and healing wounds, making it essential for patient recovery. Surgical Treatment, although smaller in market share compared to Wound Care, is witnessing rapid growth as more advanced surgical techniques and technologies are being developed.</p>

<p>Wound Care (Dominant) vs. Surgical Treatment (Emerging)</p>

<p>Wound Care stands out as the dominant application in the Gangrene Market, driven by its comprehensive range of treatment options that cater to both acute and chronic cases. This segment is characterized by innovative dressings, topical agents, and advanced therapies designed to accelerate wound healing and prevent further complications. On the other hand, Surgical Treatment is emerging as a significant segment due to increasing advancements in surgical procedures and the rising incidence of severe gangrene cases requiring operative intervention. Enhanced surgical techniques have led to improved patient outcomes, thus propelling the growth of this segment as healthcare professionals increasingly rely on surgeries alongside conventional treatment methods.</p>

By Type of Gangrene: Dry Gangrene (Largest) vs. Wet Gangrene (Fastest-Growing)

<p>In the Gangrene Market, Dry Gangrene holds the largest share, primarily due to its prevalence among patients with underlying chronic conditions, such as diabetes. This segment is characterized by the slow progression of tissue death, making awareness and early intervention pivotal in management. On the other hand, Wet Gangrene is witnessing rapid growth, propelled by an increase in infections and injuries that require prompt medical attention. Its aggressive nature requires urgent treatment, contributing to its rising prominence in healthcare discussions.</p>

<p>Dry Gangrene (Dominant) vs. Gas Gangrene (Emerging)</p>

<p>Dry Gangrene is regarded as the dominant segment in the Gangrene Market, often associated with ischemic conditions. This type results from prolonged blood flow restriction, leading to tissue necrosis without the presence of infection. Conversely, Gas Gangrene is emerging as a significant concern due to its link to bacterial infections, particularly Clostridium species. It progresses rapidly and is associated with severe tissue damage, requiring immediate intervention. Healthcare professionals are increasingly focused on understanding the underlying causes and ensuring prompt treatment for Gas Gangrene, reflecting its shift towards an emerging threat in the market.</p>

By End User: Hospitals (Largest) vs. Clinics (Fastest-Growing)

<p>In the Gangrene Market, Hospitals remain the largest segment, accounting for a significant share of the overall market due to their comprehensive facilities and access to advanced treatment options. Clinics, on the other hand, are emerging rapidly as more patients seek immediate and localized care, leading to an increase in their market share. Home care settings and ambulatory surgical centers also contribute to the market, but to a lesser extent compared to Hospitals and Clinics.</p>

<p>Hospitals (Dominant) vs. Clinics (Emerging)</p>

<p>Hospitals play a dominant role in the Gangrene Market due to their capacity to provide specialized care and manage complex cases efficiently. They are equipped with advanced medical technologies and have access to a wider range of treatment options, making them the preferred choice for severe gangrene cases. Clinics represent an emerging segment, catering to patients seeking timely interventions for gangrene management. Their growing popularity is attributed to the increased focus on outpatient care and the rise in patient awareness about early treatment. Both segments are crucial to the overall market dynamics, with Hospitals emphasizing comprehensive care while Clinics prioritize accessibility.</p>

By Treatment Method: Surgical Intervention (Largest) vs. Hyperbaric Oxygen Therapy (Fastest-Growing)

<p>In the Gangrene Market, Surgical Intervention holds the largest market share, owing to its critical role in treating severe cases of gangrene through debridement and amputation when necessary. This method is widely recognized for its effectiveness in reducing infection and complications associated with necrotic tissue. Antibiotic Therapy follows as a significant method, utilized to combat bacterial infections related to gangrene, while Wound Care Management plays a supportive role, focusing on maintaining proper wound hygiene and care. Moreover, Hyperbaric Oxygen Therapy is gaining traction as an emerging treatment option that shows promise in enhancing wound healing through increased oxygen delivery to the affected tissues.</p>

<p>Surgical Intervention (Dominant) vs. Wound Care Management (Emerging)</p>

<p>Surgical Intervention is a dominant treatment method in the Gangrene Market due to its direct and effective approach to remove infected tissue and prevent the spread of gangrene. It is often the first line of defense in critical cases, providing rapid intervention. Conversely, Wound Care Management is viewed as an emerging segment, essential for postoperative care and preventing further complications. With an emphasis on wound care products and management techniques, it supports healing and recovery. As healthcare professionals focus on holistic treatment approaches, Wound Care Management's importance is expected to grow, complementing the swift actions taken through Surgical Interventions.</p>

By Severity Level: Severe (Largest) vs. Critical (Fastest-Growing)

<p>The 'Severity Level' segment in the Gangrene Market is characterized by distinct classifications: Mild, Moderate, Severe, and Critical. The Severe category holds the largest market share, reflecting its prevalence in clinical settings where aggressive treatment is often necessary. Meanwhile, the Critical segment is emerging rapidly, driven by an increase in severe cases and heightened awareness of the condition. Mild and Moderate levels indicate milder symptoms but show less impact on overall market dynamics.</p>

<p>Severe (Dominant) vs. Critical (Emerging)</p>

<p>The Severe segment is recognized as the dominant category within the Gangrene Market, representing a substantial portion of cases that necessitate immediate medical attention. This segment includes instances of gangrene that require surgical intervention or advanced treatment modalities. The Critical segment is emerging as a key focus area for healthcare providers due to the rising incidence of critical infections and co-morbid conditions that exacerbate gangrene. Factors such as an aging population and an uptick in chronic diseases contribute to the fast growth of the Critical segment, making it a priority for research and development in new treatment options.</p>

Get more detailed insights about Gangrene Market Research Report- Forecast to 2035

Regional Insights

Key Players and Competitive Insights

The Gangrene Market is currently characterized by a competitive landscape that is both dynamic and multifaceted. Key growth drivers include an increasing prevalence of chronic wounds, advancements in wound care technologies, and a heightened focus on patient outcomes. Major players such as Johnson & Johnson (US), Smith & Nephew (GB), and Acelity L.P. Inc. (US) are strategically positioned to leverage these trends. Johnson & Johnson (US) emphasizes innovation in wound care products, while Smith & Nephew (GB) focuses on expanding its product portfolio through strategic acquisitions. Acelity L.P. Inc. (US) is enhancing its operational focus on regenerative medicine, which collectively shapes a competitive environment that is increasingly reliant on technological advancements and strategic partnerships.

In terms of business tactics, companies are localizing manufacturing to reduce costs and optimize supply chains, which is particularly crucial in a moderately fragmented market. The competitive structure is influenced by the collective actions of these key players, who are increasingly collaborating to enhance their market presence and operational efficiencies. This collaborative approach is indicative of a market that values both innovation and reliability in supply chain management.

In November 2025, Johnson & Johnson (US) announced the launch of a new advanced wound dressing that incorporates antimicrobial technology, aimed at improving healing rates for patients with gangrene. This strategic move not only reinforces their commitment to innovation but also positions them to capture a larger market share by addressing specific patient needs. The introduction of such products is likely to enhance their competitive edge in a market that is increasingly focused on patient-centric solutions.

In October 2025, Smith & Nephew (GB) completed the acquisition of a smaller biotech firm specializing in bioactive wound care products. This acquisition is significant as it allows Smith & Nephew (GB) to diversify its product offerings and strengthen its position in the gangrene treatment segment. By integrating these innovative solutions, the company is poised to enhance its competitive stance and respond more effectively to evolving market demands.

In September 2025, Acelity L.P. Inc. (US) entered into a strategic partnership with a leading telehealth provider to offer remote monitoring solutions for patients with chronic wounds. This initiative reflects a growing trend towards digital health integration, which is becoming increasingly important in managing complex conditions like gangrene. By leveraging telehealth capabilities, Acelity L.P. Inc. (US) is likely to improve patient engagement and outcomes, thereby solidifying its market position.

As of December 2025, current competitive trends in the Gangrene Market are heavily influenced by digitalization, sustainability, and the integration of artificial intelligence (AI) in product development and patient care. Strategic alliances are becoming more prevalent, as companies recognize the need to collaborate in order to innovate and enhance their service offerings. Looking ahead, competitive differentiation is expected to evolve from traditional price-based competition to a focus on innovation, technology, and supply chain reliability. This shift underscores the importance of developing advanced solutions that not only meet regulatory standards but also improve patient outcomes.

Key Companies in the Gangrene Market market include

Industry Developments

  • Customers and patients will benefit from novel healing solutions developed by market players across the care continuum, resulting in proven clinical outcomes.
  • The businesses are also expanding and developing innovative and differentiated goods and services to meet the changing demands of patients, providers, and consumers in the healthcare industry.

 

Future Outlook

Gangrene Market Future Outlook

<p>The Gangrene Market is projected to grow at a 5.76% CAGR from 2024 to 2035, driven by advancements in wound care technologies and increasing prevalence of diabetes.</p>

New opportunities lie in:

  • <p>Development of advanced antimicrobial dressings for gangrene treatment.</p>
  • <p>Expansion of telemedicine services for remote patient monitoring.</p>
  • <p>Investment in regenerative medicine to enhance tissue repair and recovery.</p>

<p>By 2035, the Gangrene Market is expected to achieve substantial growth, reflecting evolving healthcare needs.</p>

Market Segmentation

Gangrene Market End User Outlook

  • Hospitals
  • Clinics
  • Home Care Settings
  • Ambulatory Surgical Centers

Gangrene Market Application Outlook

  • Surgical Treatment
  • Wound Care
  • Diabetes Management
  • Infection Control

Gangrene Market Severity Level Outlook

  • Mild
  • Moderate
  • Severe
  • Critical

Gangrene Market Treatment Method Outlook

  • Surgical Intervention
  • Antibiotic Therapy
  • Hyperbaric Oxygen Therapy
  • Wound Care Management

Gangrene Market Type of Gangrene Outlook

  • Dry Gangrene
  • Wet Gangrene
  • Gas Gangrene
  • Internal Gangrene

Report Scope

MARKET SIZE 20241.52(USD Million)
MARKET SIZE 20251.62(USD Million)
MARKET SIZE 20352.82(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)5.76% (2024 - 2035)
REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR2024
Market Forecast Period2025 - 2035
Historical Data2019 - 2024
Market Forecast UnitsUSD Million
Key Companies ProfiledJohnson & Johnson (US), Smith & Nephew (GB), MediWound Ltd. (IL), Acelity L.P. Inc. (US), 3M Company (US), B. Braun Melsungen AG (DE), ConvaTec Group PLC (GB), Mölnlycke Health Care AB (SE), Integra LifeSciences Corporation (US)
Segments CoveredApplication, Type of Gangrene, End User, Treatment Method, Severity Level
Key Market OpportunitiesAdvancements in wound care technologies enhance treatment options in the Gangrene Market.
Key Market DynamicsRising prevalence of diabetes and vascular diseases drives demand for advanced gangrene treatment options and technologies.
Countries CoveredNorth America, Europe, APAC, South America, MEA

FAQs

  1. Introduction
    1. Definition
    2. Scope of Study
    3. Research Objective
    4. Assumptions & Limitations
    5. Market Structure:
  2. Research Methodology
    1. Research Process
    2. Primary Research
    3. Secondary Research
  3. Market Dynamics
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Challenges
    5. Macroeconomic Indicators
  4. Market Factor Analysis
    1. Porter’s five forces model
      1. Bargaining Power of suppliers
      2. Bargaining Power of Customer
      3. Intensity of Competitor’s
      4. Threat of New Entrants
  5. Global Gangrene Market, by type
    1. Introduction
      1. Dry Gangrene
      2. Wet Gangrene
      3. Gas Gangrene
      4. Others
  6. Global Gangrene Market, by Treatment
    1. Introduction
      1. Vascular Surgery
      2. Hyperbaric Oxygen Chamber
      3. Amputation
      4. Others
  7. Global Gangrene Market, by End User
    1. Introduction
      1. Hospitals
      2. Clinics
      3. Rehabilitation center
      4. Others
  8. Global Gangrene Market, by regions
    1. Introduction
      1. North America
      2. Europe
      3. Asia Pacific
      4. Middle East & Africa
  9. Company Landscape
    1. Introduction
      1. Mergers Acquisitions
      2. Collaborations
      3. Release/New Product Launches
      4. Other (Expansion, Updates, Partnership)
  10. Company Profile
    1. Advanced Medical Solutions Group plc
      1. Company Overview
      2. Product/Business Segment Overview
      3. Financials
      4. Key Developments
      5. SWOT Analysis
    2. Advanced Tissue
      1. Overview
      2. Product/Business Segment Overview
      3. Financials
      4. Key Developments
      5. SWOT Analysis
    3. Baril Corporation
      1. Overview
      2. Product/Business Segment Overview
      3. Financials
      4. Key Developments
      5. SWOT Analysis
    4. Cardinal Health
      1. Overview
      2. Product/Business Segment Overview
      3. Financials
      4. Key Developments
      5. SWOT Analysis
    5. Covalon Technologies Ltd.
      1. Overview
      2. Product/Business Segment Overview
      3. Financials
      4. Key Developments
      5. SWOT Analysis
    6. Integra LifeSciences Corporation
      1. Overview
      2. Product/Business Segment Overview
      3. Financials
      4. Key Developments
      5. SWOT Analysis
    7. MediPurpose Private Limited
      1. Overview
      2. Product/Business Segment Overview
      3. Financials
      4. Key Developments
      5. SWOT Analysis
    8. McKesson Corporation
      1. Overview
      2. Product/Business Segment Overview
      3. Financials
      4. Key Developments
      5. SWOT Analysis
    9. TRIAGE MEDITECH PVT. LTD.
      1. Overview
      2. Product/Business Segment Overview
      3. Financials
      4. Key Developments
      5. SWOT Analysis
    10. Others
  11. Appendix

Gangrene Market Segmentation

Market Segmentation Overview

  • Detailed segmentation data will be available in the full report
  • Comprehensive analysis by multiple parameters
  • Regional and country-level breakdowns
  • Market size forecasts by segment
Infographic

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Get Free Sample

Related Reports

Regional Reports
Country Reports

Customer Strories

Customer Stories
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓